INmune Bio (INMB) News
NASDAQ: INMBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.827-0.0671 (-7.50%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
INMB news summary
We found 6 recent headlines mentioning INmune Bio (INMB): 0 in the past week and 3 in the past 30 days, most often from GlobeNewswire, Nasdaq. INMB is making an outsized move today, down 7.50% at $0.827, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "INmune Bio (INMB) Q3 2026 Earnings Call Transcript", was published by Nasdaq on Nov 6, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest INmune Bio headlines
- INmune Bio (INMB) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- INmune Bio Inc. to Report Third Quarter 2026 Financial Results and Provide Corporate Update on Thursday, November 5thManagement to host conference call and webcast at 4:30 pm ET on that dayGlobeNewswire
- INmune Bio, Inc. Announces Pricing of $4.50 Million Registered Direct Offering and Concurrent Private PlacementBOCA RATON, Fla., Oct. 28, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a late-stage biotechnology company focused on inflammation and immunology, today announced that it…GlobeNewswire
- INmune Bio Advances Ebstrocel™ Toward Potential UK Approval in Mid-2027BOCA RATON, Fla., Oct. 21, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced that it…GlobeNewswire
- INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro ™BOCA RATON, Fla. and HOBOKEN, N.J., Oct. 14, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (Nasdaq: INMB) and Quantum Computing Inc. (Nasdaq: QUBT) today announced a collaboration to apply quantum…GlobeNewswireINMB, QUBT
- Weekly Buzz: JNJ, VERA Get FDA Nod; VRTX Snaps Up CRNX; MSLE Aces DMD Trial; IONS Misses Key Goal(RTTNews) - This week featured a steady stream of regulatory milestones, strategic dealmaking, and pivotal clinical trial updates, alongside missed trial goals across the biotech and pharmaceutical…NasdaqABBV, AZN, CMMB, GMAB